Top Clinical Trials companies in South Korea by Capital Expenditure
South Korea
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD -271.67 M
|
Dec. 31, 2023 | USD 119.86 | -2.20% |
|
South Korea |
|
| 2 |
USD -33.36 M
|
Dec. 31, 2023 | USD 54.68 | -7.62% |
|
South Korea |
|
| 3 |
USD -33.36 M
|
Dec. 31, 2023 | USD 240.05 | -5.25% |
|
South Korea |
|
| 4 |
USD -18.09 M
|
Dec. 31, 2023 | USD 1.61 | -1.19% |
|
South Korea |
|
| 5 |
USD -15.91 M
|
Dec. 31, 2023 | USD 11.62 | -0.90% |
|
South Korea |
|
| 6 |
USD -6.96 M
|
Dec. 31, 2023 | USD 10.77 | -3.15% |
|
South Korea |
|
| 7 |
USD -5.67 M
|
Dec. 31, 2023 | USD 3.04 | -3.81% |
|
South Korea |
|
| 8 |
USD -4.49 M
|
Dec. 31, 2023 | USD 25.27 | 1.91% |
|
South Korea |
|
| 9 |
USD -4.34 M
|
Dec. 31, 2023 | USD 1.42 | -2.25% |
|
South Korea |
|
| 10 |
USD -4.32 M
|
Dec. 31, 2023 | USD 11.00 | -3.03% |
|
South Korea |
|
| 11 |
USD -2.50 M
|
Dec. 31, 2023 | USD 70.28 | -5.55% |
|
South Korea |
|
| 12 |
USD -1.77 M
|
Dec. 31, 2023 | USD 1.01 | -3.22% |
|
South Korea |
|
| 13 |
USD -1.67 M
|
Dec. 31, 2023 | USD 1.23 | -3.88% |
|
South Korea |
|
| 14 |
USD -1.53 M
|
Dec. 31, 2023 | USD 64.97 | -2.50% |
|
South Korea |
|
| 15 |
USD -446.38 K
|
Dec. 31, 2023 | USD 17.88 | -1.83% |
|
South Korea |
|
| 16 |
USD -156.12 K
|
Dec. 31, 2023 | USD 11.83 | -21.52% |
|
South Korea |
|
| 17 |
USD -132.80 K
|
Dec. 31, 2023 | USD 2.33 | -4.21% |
|
South Korea |
Frequently Asked Questions
-
Which Clinical Trials company in South Korea has the highest Capital Expenditure ?
The Clinical Trials company in South Korea with the highest Capital Expenditure is Celltrion, Inc. (KSE: 068270.KS) at USD -271.67 M.
-
Which Clinical Trials company in South Korea has the lowest Capital Expenditure ?
The Clinical Trials company in South Korea with the lowest Capital Expenditure is MedPacto, Inc. (KOSDAQ: 235980.KQ) at USD -132.80 K.
-
What are the top 10 Clinical Trials companies in South Korea by Capital Expenditure ?
The top 10 Clinical Trials companies in South Korea by Capital Expenditure are Celltrion, Inc., ST Pharm Co.,Ltd., ALTEOGEN Inc., CrystalGenomics, Inc., Samjin Pharmaceuticals Co., Ltd., OliX Pharmaceuticals,Inc, Genexine, Inc., ABL Bio Inc., GeneOne Life Science, Inc. and Boditech Med Inc..
-
What are the bottom 10 Clinical Trials companies in South Korea by Capital Expenditure ?
The bottom 10 Clinical Trials companies in South Korea by Capital Expenditure are MedPacto, Inc., Anterogen.Co.,Ltd., Oscotec Inc., Peptron, Inc., Gencurix Inc., Enzychem Lifesciences Corporation, SK Biopharmaceuticals Co., Ltd., Boditech Med Inc., GeneOne Life Science, Inc. and ABL Bio Inc..
